Mediation of calcium-to-phosphorus ratio in the association between kidney stones and bone mineral density in the femoral neck: a cross-sectional study based on the National Health and Nutrition Examination Survey (NHANES)

This cross-sectional NHANES study reveals that kidney stones are independently associated with reduced femoral neck bone mineral density, a relationship partially mediated by an altered calcium-to-phosphorus ratio, particularly among younger individuals and those without chronic kidney disease.

The Gist

Imagine your body as a bustling city with two major construction sites: Site A is your Bones (the skyscrapers holding you up), and Site B is your Kidneys (the water filtration plant).

For a long time, city planners thought these two sites operated independently. If the filtration plant had a clog (a kidney stone), they assumed it was just a plumbing issue. If the skyscrapers started crumbling (osteoporosis), they assumed it was just an aging building problem.

But this new study suggests that Site A and Site B are actually sharing the same supply truck, and when that truck gets messed up, both sites suffer.

Here is the story of the study, broken down simply:

1. The Big Discovery: The "Leaky" Connection

The researchers looked at data from over 6,000 Americans (like a massive city census) to see if people with kidney stones had weaker bones.

• The Finding: Yes! People with kidney stones had significantly weaker bones in their hips (the femoral neck) compared to those without stones.
• The Analogy: Think of your bones as a bank account and your kidneys as a withdrawal machine. If you keep finding "stones" (withdrawals) in the machine, it turns out your bank account (bone density) is running low. They aren't just coincidental; they are linked.

2. The Culprit: The Calcium-Phosphorus "Tug-of-War"

The study asked: Why does a kidney stone make bones weak?
They found the answer in the Calcium-to-Phosphorus Ratio. Imagine Calcium and Phosphorus are two wrestlers in a ring.

• In a healthy body: They are evenly matched, keeping the balance perfect.
• In this study: People with kidney stones had a "tug-of-war" where the balance was off. The body was pulling too much calcium out of the bones to deal with the stones, or the kidneys weren't holding onto the right minerals.
• The Result: This imbalance acted as a messenger. It was the middleman that told the bones, "Hey, we need to give up some calcium," leading to bone loss. The study found this "messenger" (the ratio) was responsible for about 15% of the bone loss seen in stone patients.

3. Who is Most at Risk? The "Young and Healthy" Surprise

You might think older people are the ones with the most bone problems. But this study found a twist:

• The Younger Crowd (<50 years old): The link between stones and weak bones was strongest in younger people.
  • Why? In older people, bones get weak naturally due to age and hormones (like menopause). It's hard to tell if the kidney stone is the cause or just part of the general "aging city."
  • In younger people, whose bones should be strong, finding a kidney stone is a huge red flag. It suggests their "mineral supply truck" is broken early, and their bones are taking the hit before they even expect it.
• The Kidney Function Factor: The link was also stronger in people whose kidneys were still working well (not in kidney failure). This suggests that even "minor" kidney issues can mess with bone health before the kidneys completely shut down.

4. Why the Hips and Not the Spine?

The study noticed that the bones in the hip got weaker, but the spine didn't show the same problem.

• The Analogy: Think of the hip bone as a concrete pillar (dense, slow to change) and the spine as a sponge (porous, changes quickly).
• It turns out kidney stones seem to target the "concrete pillars" more specifically in this context, or perhaps the "sponge" in the spine is being propped up by other factors that hide the damage.

5. What Does This Mean for You?

This study changes how doctors might look at patients:

• The Warning Sign: If you are under 50 and get a kidney stone, don't just treat the stone. Check your bones! It might be a sign that your body's mineral balance is off.
• The Diet Connection: It's not just about drinking water. It's about the balance of what you eat. If your diet throws off the Calcium/Phosphorus ratio, you might be hurting your bones while trying to pass a stone.
• The Takeaway: Your kidneys and bones are best friends. If one is in trouble, the other is likely in trouble too.

In a nutshell: Kidney stones aren't just a plumbing issue; they are a warning light on your dashboard saying, "Your bone construction crew is running out of materials." Fixing the balance of minerals in your body could save both your kidneys and your skeleton.

Technical Summary

1. Problem Statement

Osteoporosis and kidney stones (nephrolithiasis) are two prevalent global health challenges. While traditionally viewed as distinct disorders affecting the skeletal and urinary systems respectively, emerging evidence suggests a bidirectional relationship: kidney stone patients often exhibit reduced bone mineral density (BMD), and bone demineralization may increase stone risk.
However, the specific mechanisms linking these conditions remain inadequately elucidated in large-scale population studies. Key questions include:

• Is there an independent association between kidney stone status and BMD in the femoral neck and lumbar spine?
• To what extent do renal function (eGFR) and calcium-phosphorus metabolism (CaP ratio) mediate this relationship?
• Are there significant variations in this association across different age, sex, and comorbidity subgroups?

2. Methodology

Study Design & Data Source:

• Design: Cross-sectional study.
• Data Source: National Health and Nutrition Examination Survey (NHANES) cycles from 2007 to 2020.
• Population: 6,464 adult participants (aged ≥20 years) with complete data on kidney stone status, BMD, and relevant biochemical markers.
• Groups: 580 participants with kidney stones vs. 5,884 without.

Variable Definitions:

• Exposure: Self-reported medical diagnosis of kidney stones.
• Outcomes: Bone Mineral Density (BMD) measured via Dual-energy X-ray Absorptiometry (DXA) at the Femoral Neck (FEBMD) and Lumbar Spine (LBMD).
• Mediators:
  • Systemic Immune-Inflammation Index (SII).
  • Estimated Glomerular Filtration Rate (eGFR) calculated via CKD-EPI equation.
  • Calcium-to-Phosphorus Ratio (CaP ratio).
• Covariates: Demographics (age, sex, race, education, PIR), anthropometrics (BMI, waist circumference), lifestyle (smoking, alcohol, physical activity), comorbidities (diabetes, hypertension), and lab values (vitamin D, calcium intake, WBC, etc.).

Statistical Analysis:

• Software: R (version 4.2.2).
• Weighting: Applied NHANES complex sampling weights to ensure national representativeness.
• Regression Models: Weighted multiple linear regression (Model 1: unadjusted; Model 2: adjusted for age/gender/race; Model 3: fully adjusted).
• Mediation Analysis: Bootstrap method (500 iterations) to calculate Average Causal Mediation Effects (ACME), Average Direct Effects (ADE), and proportion of mediation.
• Non-linearity: Restricted Cubic Spline (RCS) and B-splines to visualize dose-response relationships.
• Subgroup Analysis: Stratified by age (<50 vs. ≥50), sex, diabetes, CKD status (eGFR <60 vs. ≥60), and obesity.

3. Key Contributions

• Mechanistic Insight: This study is among the first to quantitatively demonstrate that the Calcium-to-Phosphorus (CaP) ratio acts as a significant mediator in the link between kidney stones and bone loss, accounting for approximately 15% of the total effect.
• Site-Specificity: It highlights a distinct pattern of bone loss, identifying a significant association with the femoral neck (cortical bone) but not the lumbar spine (cancellous bone), suggesting kidney stones may preferentially affect cortical bone integrity.
• Age Heterogeneity: The study challenges the assumption that the stone-bone link is uniform across ages, revealing a significantly stronger association in younger populations (<50 years) compared to older adults.
• Renal Function Nuance: It clarifies that the association is most pronounced in individuals without Chronic Kidney Disease (CKD), suggesting that in early-stage or non-CKD populations, metabolic dysregulation (rather than overt renal failure) drives the bone-stone interaction.

4. Key Results

Associations:

• Femoral Neck BMD: Kidney stone presence was significantly associated with lower FEBMD ($\beta = -0.015$, 95% CI: -0.030 to -0.001, $p = 0.046$) after full adjustment.
• Lumbar Spine BMD: No statistically significant association was found between kidney stones and LBMD ($p = 0.289$).
• Baseline Differences: The kidney stone group had significantly lower eGFR, higher CaP ratio, higher SII, and higher prevalence of diabetes and hypertension compared to the non-stone group.

Mediation Analysis:

• CaP Ratio: Identified as a significant mediator (ACME = 0.00077, $p = 0.028$), explaining 14.7% of the total effect.
• eGFR & SII: Neither renal function (eGFR) nor systemic inflammation (SII) showed statistically significant mediating effects in this model.

Subgroup & Interaction Findings:

• Age: The negative association was significant in participants <50 years ($\beta = -0.025$, $p = 0.039$) but attenuated and non-significant in those $\ge50$ years.
• CKD Status: The association was significant in participants without CKD ($\beta = -0.024$, $p = 0.005$) but absent in those with CKD.
• Sex: No significant interaction by gender was detected, though dose-response curves varied slightly between males (U-shaped) and females (non-monotonic).

Dose-Response:

• eGFR vs. BMD: A non-linear relationship was observed. BMD declined sharply when eGFR dropped below 60 mL/min/1.73m² but plateaued when eGFR exceeded 90 mL/min/1.73m².
• CaP Ratio vs. BMD: A significant non-linear association was observed, varying by sex.

Sensitivity Analysis:

• Restricting the analysis to patients with eGFR $\ge30$ mL/min/1.73m² confirmed the robustness of the primary findings.

5. Significance and Clinical Implications

• Early Screening: Patients with kidney stones, particularly those under 50 and without CKD, should be considered a high-risk group for osteoporosis. Clinicians are advised to screen for BMD reduction in these populations.
• Metabolic Management: The findings underscore the importance of monitoring and correcting calcium-phosphorus homeostasis. Interventions targeting the CaP ratio (e.g., dietary adjustments, thiazide diuretics for hypercalciuria) may serve a dual purpose: preventing stone recurrence and preserving bone density.
• Pathophysiological Understanding: The study supports the hypothesis that shared metabolic pathways (specifically hypercalciuria and altered CaP metabolism) drive the comorbidity of nephrolithiasis and osteoporosis, rather than just shared risk factors like age or inactivity.
• Limitations: As a cross-sectional study, causal inference is limited, and reliance on self-reported stone diagnosis introduces potential misclassification. However, the use of a large, nationally representative dataset and rigorous statistical adjustments strengthens the validity of the epidemiological associations.

Conclusion:
Kidney stones are independently associated with reduced femoral neck bone mineral density, a relationship partially mediated by an altered calcium-to-phosphorus ratio. This link is most critical in younger, non-CKD populations, suggesting that bone health monitoring should be integrated into the management of kidney stone disease.